feed,title,long_url,short_url
Benzinga,"The Global Primary Immunodeficiency Therapeutics Market is expected to grow by $ 3.13 bn during 2022-2026, accelerating at a CAGR of 7.73% during the forecast period",https://benzinga.com/pressreleases/22/05/g27468744/the-global-primary-immunodeficiency-therapeutics-market-is-expected-to-grow-by-3-13-bn-during-2022,
